Triplet combinations of immunotherapy and targeted treatments as first-line therapy for advanced renal cell carcinoma

KEYMAKER-U03 is an international, multicenter, open-label, Phase I/II umbrella trial evaluating experimental combinations of ...
Fierce Pharma

Merck eyes life after Keytruda LOE with Welireg kidney cancer wins

As Merck looks for growth opportunities ahead of Keytruda’s tumble over the patent cliff, the company’s future now looks a ...

Merck's New Cancer Therapy Combo Shows Significant Edge Over Rivals In Renal Cancer

Merck and Eisai report Phase 3 results showing Welireg plus Lenvima significantly improved progression-free survival in ...
Targeted Oncology

Non–Clear Cell RCC Trials Support Regimens Approved for Clear Cell RCC

Sweis, MD, and participants discussed their impressions of combination trials in non–clear cell renal cell carcinoma.
The Bakersfield Californian

Xencor Presents Initial Data for XmAb819, a First-in-class ENPP3 x CD3 Bispecific T-Cell Engager, in Development for Clear Cell Renal Cell Carcinoma

We are excited to be developing XmAb819 as a novel first-in-class ENPP3 T-cell engager that could potentially offer a ...

Xencor to Host Webcast and Conference Call to Discuss Initial Results from the Ongoing Phase 1 Dose-Escalation Study of XmAb819 in Advanced Clear Cell Renal Cell Carcinoma

Xencor, Inc. (NASDAQ:XNCR), a clinical-stage biopharmaceutical company developing engineered antibodies for the treatment of cancer and autoimmune diseases, will host a conference call and webcast on ...
Cure Today

Dual-Targeting CAR T Therapy Shows Potential in Advanced Kidney Cancer

CAR T-cell therapy is being adapted for clear cell renal cell carcinoma, targeting CAIX and CD70 to improve efficacy and safety. Early trials like COBALT-RCC and TRAVERSE show promising disease ...
People

Teen Thought She Was Having First Period. Then Her Heavy Bleeding Was Dismissed as Pandemic Stress Before Shocking Diagnosis

Liliana 'Lili' Castaneda, 14, was diagnosed with a rare vaginal cancer called clear cell carcinoma Becca Longmire is a digital news writer-reporter at PEOPLE. She has been working at PEOPLE since 2024 ...